EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 128 filers reported holding EPIZYME INC in Q2 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $234,000 | -74.1% | 204,230 | -43.6% | 0.00% | – |
| Q4 2021 | $905,000 | -11.9% | 362,180 | +80.6% | 0.00% | – |
| Q3 2021 | $1,027,000 | -28.1% | 200,535 | +16.7% | 0.00% | – |
| Q2 2021 | $1,428,000 | +258.8% | 171,849 | +276.1% | 0.00% | – |
| Q1 2021 | $398,000 | -38.9% | 45,694 | -23.8% | 0.00% | – |
| Q4 2020 | $651,000 | +41.2% | 59,975 | +55.3% | 0.00% | – |
| Q3 2020 | $461,000 | -20.4% | 38,618 | +7.1% | 0.00% | – |
| Q2 2020 | $579,000 | +238.6% | 36,049 | +117.7% | 0.00% | – |
| Q3 2019 | $171,000 | -15.8% | 16,558 | +1.0% | 0.00% | – |
| Q1 2019 | $203,000 | -25.6% | 16,401 | +6.5% | 0.00% | -100.0% |
| Q1 2018 | $273,000 | +89.6% | 15,405 | +37.7% | 0.00% | 0.0% |
| Q3 2015 | $144,000 | -53.4% | 11,187 | -1.8% | 0.00% | -66.7% |
| Q3 2014 | $309,000 | -42.1% | 11,396 | -33.6% | 0.00% | -57.1% |
| Q2 2014 | $534,000 | – | 17,175 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |